8 items found in 1 pages
An interview with Warren Luk, CEO of Good Lab, a Hong Kong-based social innovation think-and-do tank (Alumni series)
We speak with Warren Luk, a former student in Economics & Statistics at UCL, about his time at the university, how important extra-curricular activities are, and what his career path has been since he ventured into the world. Links: https://www.goodlab.hk/
14
2/15/2024
Ask the Expert Slade Admissions Special
UCL East Schools Engagement Roberta Livingston discusses all things Slade Admissions with Kate Bright from the Slade School of Fine Art.
4
11/6/2023
Ask the Expert - Admissions Special
In this episode UCL East Schools Engagement Assistant Roberta Livingston hosts an Admissions special with notes and guidance provided by the UCL Admissions Team.
3
11/6/2023
Octopus (part 3): The patients’ experience with Dawn Lyle and Matthew Justin
Octopus is a new clinical trial for people living with progressive multiple sclerosis (MS), which is designed and run by the MRC Clinical Trials Unit at UCL. Thanks to its multi-arm multi-stage platform design, Octopus has the potential to transform the way treatments for progressive MS are tested. The trial is now open in the UK and will be recruiting participants for the next few years. The podcast mini-series will explore the trial from different perspectives by talking to neurologists, MS experts and people affected by MS. In Part 3, MS experts Dawn Lyle and Matthew Justin walk us through the journey that trial participants take when taking part in Octopus, from how to register your interest in the trial, to what to expect on your first visit.
3
11/1/2023
Episode 9 (part 1): Octopus: The multiple sclerosis landscape with Jeremy Chattaway, Dawn Lyle and Matthew Justin
Octopus is a new clinical trial for people living with progressive multiple sclerosis (MS). Thanks to its multi-arm multi-stage platform design, Octopus has the potential to transform the way treatments for progressive MS are tested. The trial is now open in the UK and will be recruiting participants for the next few years. The podcast mini-series will explore the trial from different perspectives by talking to neurologists, MS experts and people affected by MS. Part 1 covers the treatment and research landscape of MS and the challenges of treating progressive MS. It features Jeremy Chataway, neurologist at National Hospital for Neurology and Neurosurgery at UCLH and Professor of Neurology at UCL, who is leading the Octopus trial. We also hear from Dawn Lyle, Lead Research MS Nurse, and Matthew Justin, MS Specialist, who are based at the Anne Rowling Regenerative Neurologic Clinic in Edinburgh.
4
10/19/2023
The REFINE trial: how can we improve the way we give cancer immunotherapy?
Immunotherapy drugs fight cancer by helping the immune system recognise and attack cancer cells. These drugs have revolutionised cancer treatment over the last decade, improving survival for many people with different types of cancer. However, researchers are still unsure of the best way to give immunotherapy, which can come with unpredictable side effects. In this episode, Clinical Fellow Sophie Merrick discusses how the REFINE trial hopes to address this problem, by testing if giving immunotherapy less frequently can still treat the cancer effectively, whilst improving the quality of life for patients, reducing side effects and costs. Further information is available on the REFINE study page at www.mrcctu.ac.uk For questions or feedback on the series, message us at mrcctu.engage@ucl.ac.uk For more information and to access the transcript: https://bit.ly/3DgIDE2
0
7/18/2023
UCLB – Big Talks on Big Impacts Episode 4 : e-lucid: developing an innovative express licensing platform
In the fourth episode of this podcast series, UCLB’s Director of Engineering and Physical Sciences, Dr Steven Schooling, is in conversation with Marina Santilli, UCLB Associate Director, Engineering & Physical Sciences about the development and scaling of UCLB’s express licensing platform e-lucid (https://e-lucid.com/). Early in her UCLB career, Marina recognised that there was a need for more effective tools to manage the licensing of lower value IP assets such as software and materials and in this podcast they discuss the journey from creating a minimum viable solution which addressed UCLB’s initial licensing needs through to the evolution of the e-lucid platform into a tool which has been adopted by some of the world’s leading universities, technology transfer and research organisations as they seek to enhance their impact outcomes.
14
4/19/2023
Staying positive: Gideon on how to do life in academia
Academia et al. podcast guest Dr Gideon Sappor shares his top tip for life as an early career academic. Listen to the podcast episode: bit.ly/aea-s01e01
699
1/11/2022